Depression in people with intellectual disability is a clinically recognizable depressive disorder that may involve persistent low mood or loss of interest, changes in sleep, appetite, energy, thinking, and daily participation, and sometimes changes in behavior that are easier to observe than to describe. Intellectual disability affects intellectual and adaptive functioning; it does not make depressive illness an expected feature of the person's identity. A person who communicates through speech, gestures, pictures, an augmentative and alternative communication system, or behavior can experience depression and deserves a careful assessment and access to treatment. The most reliable clinical approach combines the person's own account wherever possible, a comparison with their usual functioning, observations from people who know them well, a search for physical and environmental explanations, and adapted evidence-based depression care. NICE NG54 provides the principal disability-specific clinical framework.
What Depression Means in the Context of Intellectual Disability
Intellectual disability is characterized by significant limitations in intellectual functioning and adaptive behavior beginning during the developmental period. Adaptive behavior involves conceptual, social, and practical skills used in everyday life. Depression is a separate mental-health condition. Both can coexist, and the clinical questions about each are different: intellectual disability establishes a developmental profile of functioning and support needs, while a depressive episode concerns a change in mood, interests, energy, cognition, bodily functions, and impairment across time. The distinction is essential because preexisting communication limitations or reliance on assistance should never be mistaken for a newly acquired depressive symptom. AAIDD and NICE NG54 support these distinct assessments.
The term intellectual disability is standard in American English. In British NICE guidance, learning disability generally refers to intellectual disability rather than the narrower American category of specific learning disorder. This lexical difference matters when searching research or applying guidelines. Depressive disorders are diagnosed by clinical evaluation of symptom patterns, duration, functional change, exclusion of alternative explanations, and relevant psychiatric diagnostic criteria. A rating scale may help identify and track symptoms, but a scale score is not by itself a diagnosis. An isolated episode of sadness after a loss is likewise a different clinical question from a sustained depressive syndrome.
Why Depression Can Be Missed
People with intellectual disability encounter recognizable barriers to mental-health diagnosis: clinicians may have insufficient specialist training, standard interviews may assume levels of verbal abstraction that the person does not use, and observers may interpret symptoms through the existing developmental diagnosis. The resulting diagnostic overshadowing can delay treatment when fatigue, social withdrawal, agitation, or loss of skills is casually attributed to intellectual disability rather than investigated as a new health concern. See the related scientific article on diagnostic overshadowing in intellectual disability.
The opposite error also occurs: a behavioral change may be labeled depression without investigating pain, seizures, medication effects, sensory stress, loss of support, grief, trauma, or disruption of an established routine. Disability-informed practice therefore requires a balanced formulation that tests both mental-health and nonpsychiatric explanations. The European guideline on psychiatric assessment in adults with intellectual disabilities and NICE NG54 recommend a broad, contextual, multidisciplinary approach.
Signs and Symptoms of Depression
Changes in Mood, Pleasure, and Motivation
The most informative psychological signs include sustained sadness, loss of enjoyment in previously valued activities, diminished initiative, hopelessness, low self-regard, frequent crying, and changes in emotional responsiveness. The individual may report feeling unhappy, lonely, frightened, exhausted, or useless using their own words, symbols, or preferred communication method. Clinicians should explore the meanings of those expressions rather than insisting on psychiatric vocabulary. Depression may also be accompanied by irritability, anxiety, and increased sensitivity to frustration, although these signs are nonspecific and require clinical interpretation. NICE NG54.
Loss of interest is particularly important when it represents an observable departure from the person's established pattern. Someone who usually anticipates a weekly activity may begin refusing it, or a person who reliably enjoys music, visiting friends, or a preferred hobby may show markedly less pleasure. Such observations gain diagnostic value when they are persistent, occur in more than one setting, and accompany other depressive features. A single missed activity is insufficient evidence, especially if the setting has become inaccessible or unpleasant.
Sleep, Appetite, Energy, and Physical Symptoms
Depression may coincide with sleeping substantially more or less than usual, early waking, altered appetite or weight, slowing or restlessness, fatigue, and reduced concentration. Somatic and vegetative symptoms can sometimes be more visible than verbal descriptions of depressed mood. Yet sleep disorders, gastrointestinal discomfort, chronic pain, thyroid disease, anemia, infection, epilepsy, and medication adverse effects can produce similar features. Clinicians need to ask what has changed, how long the change has persisted, and whether the pattern relates to an identifiable medical or environmental factor. A physical-health assessment remains part of a depression assessment, especially when the person cannot readily localize pain or describe adverse effects. NICE NG54.
Changes in Participation and Adaptive Functioning
Depression can reduce activity, learning engagement, self-care participation, communication, and social contact. A person may require more prompts to begin a familiar task, abandon an enjoyable routine, or appear less responsive during interactions. In someone with substantial support needs, the change may be documented through activity logs and accounts of familiar caregivers. Reduced task performance should be interpreted relative to that individual's usual skills, available supports, and environmental opportunities rather than against general-population norms. Changes in the amount of support provided can themselves change performance without indicating a psychiatric disorder.
Agitation, Withdrawal, and Behavior That Communicates Distress
A person may express psychological distress through pacing, refusal, heightened irritability, increased reassurance-seeking, withdrawal, tearfulness, or aggression. Self-injury or another crisis behavior may sometimes coexist with depression, but such behavior does not establish depression and can signal acute pain, trauma, unmet communication needs, or environmental distress. Functional behavioral assessment may help reveal antecedents and consequences; it belongs alongside medical and psychiatric evaluation rather than replacing it. The separate article on challenging behavior in intellectual disability examines this broader assessment problem. NICE NG11 and NICE NG54 address coordinated evaluation.
How Symptoms Vary With Communication and Support Needs
Adults with milder intellectual disability may describe sadness, guilt, negative expectations, or thoughts about death directly, especially when questions are concrete and phrased in accessible language. Others find abstract questions about mood difficult but can answer about events, preferences, sleep, energy, and daily activities. A clinician might ask how the person feels when waking, which activities have become harder, or whether favorite activities still feel enjoyable, using pictures, response cards, or examples chosen by the person. This is an adaptation of access rather than a relaxation of diagnostic standards.
For people with moderate, severe, or profound intellectual disability, observable longitudinal changes and contextual information may become more important, but the person's communication remains central. Facial expressions, body movement, sensory preferences, vocalization, approach and avoidance, and responses to trusted communication partners may carry meaning. Interpretations should be triangulated across settings and observers. Caregivers' observations are valuable evidence about change; they remain proxy reports and should never erase the individual's preferences or known communicative signals. NICE NG54, assessment recommendations.
Clinical Criteria, Duration, and Depressive Disorders
A major depressive episode ordinarily involves a sustained cluster of symptoms, including depressed mood or diminished interest or pleasure, with associated cognitive, physical, and functional changes over a clinically relevant duration. Clinicians apply formal diagnostic criteria while accounting for the person's developmental level and communication. The two-week minimum used in major depression criteria provides a useful temporal anchor; the individual case still requires assessment of the full symptom pattern, clinically significant change, impairment, and possible substance-related or medical causes. Chronic depressive presentations, adjustment-related symptoms, bereavement, bipolar depression, and depression associated with another disorder require distinct judgments.
The specialist task is to identify how a symptom can be established reliably for this particular person. An answer that cannot be elicited through an abstract question may be accessible through a concrete prompt, visual aid, behavioral observation, or longitudinal account. Clinical judgment must also recognize the uncertainty of inferential measures, especially when a symptom such as guilt or worthlessness has no direct observable equivalent. The European psychiatric assessment guideline describes the need for careful diagnostic adaptation.
Risk Factors and the Person-Environment Context
Depression is multifactorial. The presence of intellectual disability alone neither specifies an episode's cause nor predicts an individual's future mental health. Relevant contributors can include a personal or family history of mood disorder, previous depression, ongoing pain or illness, sleep disruption, trauma, bullying, exclusion, abuse, bereavement, loneliness, unstable caregiving relationships, and limited control over daily decisions. The relative importance of each factor varies widely. These factors are often associated with distress, but an association cannot automatically establish an individual's mechanism of depression.
The social ecology of care matters. A sudden change in residence, frequent turnover among support workers, removal from preferred activities, loss of contact with family, or transition between services can reduce familiar sources of security and reward. Others may experience distress when their communication is misunderstood or their expressed wishes are disregarded. A sound formulation asks what happened before symptoms began, what support and opportunities changed, and which protections remain. For the broader clinical picture, see mental health problems in people with intellectual disability.
Diagnostic Assessment: A Practical Clinical Sequence
Establish the Individual's Baseline
The first task is to document the person's usual mood expression, interests, sleep, energy, social habits, activity level, communication, independence, and need for assistance. This baseline can come from the individual, past health records, longstanding supporters, and recent logs. An apparent loss of ability can only be interpreted against what the person previously did and what opportunities were available. A structured chronology identifies onset, changes in severity, major life events, medication adjustments, possible trauma, and whether symptoms appear across contexts.
Interview the Person Using Accessible Methods
The person's account should be sought directly, with enough time, plain language, one idea per question, opportunities to ask for clarification, and their preferred communication support. Clinicians can use visual emotion scales, concrete examples, photographs of activities, supported communication, and consistent yes/no responses when these genuinely match the individual's communicative competence. Leading questions and suggestibility are recognized hazards; repeated agreement alone does not confirm a symptom. Confidentiality, privacy, accessible explanations, and assent or consent processes appropriate to applicable law and capacity are necessary. The objective is to obtain the most reliable expression of the person's experience, not merely a proxy's interpretation. NICE NG54.
Collect Contextual Accounts Without Substituting Them for Self-Report
Family, support workers, educators, and clinicians may each witness different aspects of functioning. Collect concrete observations: dates, events, duration, frequency, and contrast with baseline. Ask whether changes are confined to one environment or follow sleep disturbance, staffing changes, interpersonal conflict, pain, or interrupted communication. Differences between observers are often diagnostically useful. They may reflect variation in the person's environments, unequal opportunity to participate, or the observer's perspective. NICE advises reviewing assessments when significant differences arise between the person's account and other observers' accounts. NICE NG54.
Assess Physical Health, Medicines, and Neurological Conditions
A depression evaluation should review pain, dental disease, constipation or gastrointestinal problems, menstrual or reproductive health where relevant, sleep disorders, sensory changes, seizures, endocrine conditions, and other plausible conditions suggested by clinical history. Physical examinations and tests should be clinically indicated, not applied indiscriminately. Review all medications, including antiseizure drugs, sedatives, antipsychotics, steroids, and recently changed treatments, for potential mood, energy, sleep, or movement effects. Where a person has extensive medical comorbidity, collaboration with primary care and specialists can be indispensable. The aim is to identify treatable contributors and avoid attaching an unsupported psychiatric explanation to every new difficulty. NICE NG54.
Evaluate Safety and Function
A mental-health evaluation should include the possibility of suicidal thinking, self-harm, severe neglect of basic needs, exploitation, abuse, and other immediate risks, phrased accessibly and without assuming that intellectual disability prevents suicidal intent. A person who describes wanting to die, shows new potentially lethal behavior, or experiences sudden major deterioration requires timely, qualified risk assessment. A structured safety plan can identify whom to contact, warning signs, means-safety steps, communication supports, and crisis services. Acute medical danger warrants emergency assessment. Behavioral manifestations alone should never be used as a shortcut to infer suicidal intent or its absence. NICE NG54 and NICE NG222.
Depression Rating Scales: Glasgow and Other Measures
The Glasgow Depression Scale for people with a Learning Disability (GDS-LD) was developed for adults with milder intellectual disability, alongside a Carer Supplement designed to gather observations across a broader range of support needs. In its original validation study, the self-report scale differentiated selected groups with and without depression and demonstrated encouraging psychometric performance. Those original findings support use as a structured aid, not a universally transportable diagnostic threshold. Scores can vary with language, cognitive profile, communication supports, psychiatric comorbidity, and assessment setting. Cuthill, Espie, and Cooper (2003).
NICE recommends considering a formal depression measure, such as the Glasgow self-report version for adults with milder learning disabilities or the carer supplement for adults across levels, especially to monitor change over time. The evidence quality depends on population match and accurate administration. Measures designed for the general population, including standard PHQ-9 forms, should not automatically be presumed validated in every intellectual-disability population; clinicians must evaluate suitability and interpretability. When a scale is used repeatedly, the same accessible method and comparable observer conditions make change easier to interpret. NICE NG54, 1.7.8–1.7.11.
Differential Diagnosis: Conditions That Can Resemble Depression
Pain and untreated physical illness can produce fatigue, reduced activity, irritability, or withdrawal. Sleep apnea, insomnia, medication sedation, and seizure-related changes can alter attention and energy. Grief and adjustment to adversity can share sadness or disrupted routines with depression; the distinction depends on the overall pattern, persistence, functional impact, and clinical context. Anxiety may produce avoidance and agitation. Trauma-related distress may emerge as vigilance, interpersonal withdrawal, or disrupted sleep. Bipolar disorder requires special attention to previous episodes of mania or hypomania because treatment planning differs. Psychotic phenomena need careful evaluation when reported or behaviorally suspected.
Loss of functioning later in life, particularly in some genetic syndromes such as Down syndrome, may prompt assessment for dementia or another neurocognitive condition alongside depressive illness. Conversely, depression can mimic cognitive deterioration through reduced attention and participation. Autism and intellectual disability can coexist, but autistic communication differences and sensory needs should be assessed on their own terms. The published article on autism and intellectual disability in adults owns that separate differential question. Diagnostic formulation should allow multiple contributors rather than forcing an exclusive single explanation. NICE NG54.
Psychological Treatment and Adaptation
Adapted Cognitive Behavioral Therapy
Cognitive behavioral therapy (CBT) can be adapted for a person who benefits from structured, concrete learning. Adaptations may include shorter or slower-paced sessions, straightforward vocabulary, pictures, repetition, behavioral rehearsal, visual mood scales, accessible written materials, and active practice between visits. A therapist can help the person link events, feelings, thoughts, and actions with examples from their own life. Some components depend on verbal or reflective ability; the treatment plan should select methods that are meaningful to that individual rather than rely on an assumed uniform cognitive level. A trusted supporter may help with practice when the person agrees, with confidentiality and choice protected.
NICE specifically recommends considering adapted CBT for depression or subthreshold depressive symptoms in people with milder intellectual disability and aligning adaptations with communication, preferences, strengths, and the person's desired outcomes. That is a clinical guideline recommendation supported by a limited specialist trial base, rather than evidence that every standard CBT protocol has the same effectiveness across all disability levels. NICE NG54, 1.8.2–1.8.5. A small pilot study of group CBT reported encouraging outcomes among adults with mild intellectual disability, but the sample was too small to establish a general effect size for the wider population. Hartley et al. (2015).
Behavioral Activation and Guided Self-Help
Behavioral activation focuses on restoring achievable, personally meaningful activities and reducing patterns of avoidance. For people who find extended abstract discussion difficult, a jointly developed activity plan may be more accessible than a complex cognitive worksheet. Activities must reflect actual choice, sensory needs, transport availability, health limitations, and the person's preferences. The goal is to rebuild access to valued experiences, connection, and reinforcement; it is not to increase compliance with someone else's schedule.
In the multicenter BeatIt randomized trial, 161 adults with mild or moderate intellectual disability and clinically significant depression were allocated to adapted behavioral activation or guided self-help. At 12 months, the investigators found no significant difference in Glasgow Depression Scale outcomes between the treatments. Depression scores improved within both groups, but without an untreated comparator those within-group improvements cannot establish either intervention's efficacy independently. The appropriate finding is that behavioral activation was not demonstrated to outperform the active guided self-help comparison. Jahoda et al. (2017)30426-1).
A later feasibility study of a behavioral activation approach adapted for adults with severe or profound intellectual disability reported acceptability but could not complete the planned randomized efficacy trial after COVID-related disruption. Feasibility and acceptability support future evaluation; they do not establish treatment effectiveness in that population. BeatIt2 feasibility study (2024).
Supportive, Family, and Environmental Interventions
A treatment plan may include practical changes that make psychological therapy usable: accessible transportation, reliable appointment reminders, assistance with chosen activities, consistent communication tools, and opportunities for relationships and participation. When isolation, trauma, or an inaccessible environment is maintaining distress, treatment should address those circumstances directly. Family members and supporters can help identify what matters to the person, monitor symptoms, and carry out agreed steps; their involvement should be consensual, purposeful, and proportionate. Therapy is delivered to the person, not simply through instructions to others. NICE NG54.
What Scientific Reviews Establish About Therapy
A systematic review of nonpharmacological interventions for depression in adults with intellectual disability identified 15 eligible studies among more than four thousand screened records and considered CBT, other behavioral therapies, exercise, social problem solving, and bright-light approaches. The reviewers found only a limited number of strong studies; several CBT-focused investigations produced encouraging results, and more rigorous trials with follow-up were needed. These conclusions support access to adapted psychological care and careful outcome evaluation, while leaving considerable uncertainty about optimal intervention, intensity, and applicability to people with the highest support needs. Hamers et al. (2018).
Evidence should be classified by the particular claim. It is established that depression can occur in people with intellectual disability and requires clinical assessment; established guideline practice calls for individualized access and reasonable adaptations. Evidence supporting adapted CBT in milder disability is promising but limited relative to general-population depression research. BeatIt provides a randomized comparison between two active support approaches, not proof that one specific treatment is superior. For severe or profound disability, intervention feasibility evidence is preliminary and efficacy estimates remain limited. Clear distinctions protect readers from treating an appealing clinical approach as if effectiveness had been conclusively demonstrated in every population.
Antidepressant Medication: Indications and Cautions
A person with intellectual disability and depression may benefit from antidepressant medication when a clinician determines that the expected benefit is appropriate to the severity, clinical history, personal preference, comorbidity, and available alternatives. Intellectual disability by itself is neither a reason to refuse treatment nor an indication for medication. For general adult depression, NICE NG222 describes shared decision-making, the option of psychological treatment and medication according to severity, careful attention to adverse effects, and appropriate reviews. Disability-specific guidance adds communication access, medication-interaction checks, coordinated monitoring, and the individual's involvement in treatment choices. NICE NG222; NICE NG54.
SSRIs are often considered in routine adult depression practice, but the direct randomized evidence specific to intellectual disability is substantially smaller than the general depression evidence base. A prescription must therefore be clinically individualized. Review seizure disorders, other neurological conditions, use of antiseizure or psychotropic medicines, potential drug interactions, sleep, appetite, and the person's capacity to notice and report adverse effects. The person and supporters can agree on accessible ways to track both benefit and harm; a new agitation, gastrointestinal complaint, sleep change, unusual fatigue, or worsening mood deserves timely review rather than automatic attribution to disability. NICE NG54, medication recommendations.
NICE advises that specialists with expertise in intellectual disability and mental health start medication for adults with more severe learning disabilities unless there are locally agreed shared-care arrangements, and for children or adolescents with any level of learning disability. Polypharmacy should be reviewed regularly. Antipsychotics are not a generic treatment for sadness or challenging behavior, and their long-term continuation without a clear indication needs review. Medication selection, dosage, tapering, and switching should be managed by qualified prescribers; abrupt discontinuation can create withdrawal symptoms or clinical deterioration. NICE NG54.
When Depression Is Severe or Urgent
Marked inability to maintain eating, drinking, basic care, or safety; psychotic symptoms; signs of mania; suicidal thinking; and escalating self-harm require immediate or rapid specialist assessment according to their severity. Communication barriers can complicate risk disclosure, so clinicians should use accessible direct questions, examine patterns of behavior, and include trustworthy collateral information while respecting the person's autonomy. Plans for crisis access should state how to communicate distress, which professionals know the person, and who will coordinate emergency support. A caregiver's concern that a person is suddenly and profoundly different from baseline is clinically important even when the person cannot describe the change verbally.
Treatment of severe or complex depression may require coordinated community mental-health, intellectual-disability, medical, and sometimes hospital-based services. General depression guidance discusses escalation of care and specialized options, while disability-specific guidance addresses adjustments and the rights of the person receiving treatment. Any advanced intervention demands an individual specialist evaluation of capacity, consent, medical suitability, evidence, and local legal safeguards. NICE NG222; NICE NG54.
Depression in Children and Adolescents With Intellectual Disability
Children and adolescents may communicate depressive distress through loss of pleasure, persistent irritability, withdrawal from play or social interaction, changes in sleep or eating, deterioration in engagement, and changes in familiar routines. School refusal or reduced participation can have many causes, including bullying, sensory overload, anxiety, educational mismatch, and medical illness. Developmentally appropriate assessment must combine the child's own accessible communication, caregivers' observations, school context, and pediatric physical and mental-health review. A behavior problem is not a psychiatric diagnosis, and a developmental disability does not remove the need to investigate depressive symptoms.
Evidence for disorder-specific psychological treatments adapted to children with intellectual disability is particularly limited. NICE identifies the need for randomized studies of interventions for internalizing disorders in this age group. Treatment should therefore follow relevant child and adolescent depression pathways with expert adaptation, safeguarding, accessible communication, and attention to the family and educational environment. Medication decisions require specialist expertise and age-appropriate safety standards. NICE NG54 research recommendations.
Depression in Older Adults and Changing Health Profiles
Older adults with intellectual disability may encounter bereavement, reduced community access, chronic illnesses, sensory loss, and changing support networks. A depressive episode can present as reduced motivation, altered sleep, weight changes, distress, or apparent decline in daily functioning. At the same time, emerging dementia, sensory impairment, medication effects, and physical illness can produce overlapping signs. Differential diagnosis should examine the time course of changes, cognitive and adaptive trajectories, and observations from the person's established support network. Some etiologic groups, particularly people with Down syndrome, require syndrome-informed awareness of age-related conditions. NICE NG54.
The clinical question remains individualized: which changes indicate altered mood, which suggest disease or environmental adversity, and which may coexist? Treatable depression should be considered during evaluation of cognitive decline. Dementia assessment may benefit from longitudinal measures of functioning and syndrome-appropriate instruments, while depression assessment requires its own symptom and safety evaluation. Care should prioritize participation, the person's preferences, comfortable communication, and continuity between mental-health and general medical services.
Building a Person-Centered Treatment Plan
A comprehensive plan identifies the individual's own goals, the working clinical formulation, desired outcomes, chosen interventions, and responsibilities for treatment delivery. An outcome may include returning to a preferred activity, sleeping more consistently, reestablishing contact with friends, feeling less distressed, or reducing the amount of unwanted support required to enjoy daily life. Goals should be collaboratively chosen and meaningful to the person rather than limited to what staff find easy to count.
The plan should identify who coordinates care, what communication aids are needed, when symptoms and possible adverse effects will be reviewed, and how the team will respond to emerging risk. Simple mood charts, visual scales, diaries of chosen activities, and individualized functional observations can supplement a standardized instrument. Data should support treatment decisions rather than become an end in themselves. NICE calls for integrating mental-health plans with other care plans and agreeing on review responsibilities. NICE NG54, 1.7.19–1.7.21.
Monitoring Response, Recovery, and Relapse
Recovery has clinical and lived dimensions. A decrease in depression-scale scores may represent important improvement, but the person's regained pleasure, confidence, agency, relationships, and participation also matter. Monitoring should combine self-reported wellbeing, symptom measures when suitable, observable changes from baseline, side effects, and relevant functional goals. Treatment adaptation may be needed if the person does not understand materials, cannot access appointments, or experiences unwanted supporter involvement. The absence of progress should prompt reconsideration of diagnosis, medical causes, environmental stressors, intervention fit, and the quality of treatment delivery.
Relapse prevention can include a personally accessible list of warning signs, agreed coping routines, access to enjoyable activities, trusted contacts, clear medication review arrangements where relevant, and a plan to seek reassessment if symptoms return. Services should prepare for transitions between homes, employment, school, and healthcare systems because continuity of support may affect opportunities for recovery. The person should receive a plan they can use in their preferred communication format. NICE NG54; NICE NG222.
What Families, Support Workers, and Clinicians Can Do
The most useful first response to a concerning change is systematic curiosity. Record concrete observations and dates, ask the individual how they feel in an accessible way, look for changes in health, medication, relationships, sleep, and environment, and arrange an appropriate clinical assessment. Supporters can protect access to preferred activities and social connection, assist with agreed care routines, and communicate findings to clinicians. They should avoid treating refusal, withdrawal, or agitation as evidence of depression in isolation; equally, they should take new distress seriously even when its source is uncertain.
Services can improve recognition by training staff to notice baseline change, using accessible mental-health information, involving disability-aware clinicians, coordinating primary and psychiatric care, and documenting responsibilities during transitions. Clinicians should speak directly to the person, offer meaningful choices, and address communication barriers during informed consent and follow-up. The person remains the primary participant in decisions about their health. NICE NG54.
Research Limitations and Outstanding Questions
Depression research involving people with intellectual disability is affected by variable case definitions, differences in cognitive and communication profiles, small samples, limited outcome standardization, and inconsistent reporting of adaptation methods. Many intervention trials disproportionately include participants with mild or moderate intellectual disability, while those with severe or profound disability remain underrepresented. Observational measures, proxy reports, and self-reports capture overlapping but distinct phenomena and cannot be treated as interchangeable. Studies also differ in follow-up duration and in whether outcomes include meaningful participation and quality of life.
High-priority research questions include the reliability and cross-cultural validity of accessible depression assessment; comparative effectiveness and adverse effects of pharmacological treatment in specific intellectual-disability populations; adaptation fidelity in psychological therapies; trials including people with complex communication needs; and the long-term consequences of person-centered environmental interventions. Participatory research can improve which outcomes matter and how results are interpreted. In this area, scientific precision requires stating when evidence is established, promising but limited, or preliminary, and keeping causal conclusions proportional to study design. Hamers et al. (2018); NICE NG54 research recommendations.
Frequently Asked Questions
Can a Person With Intellectual Disability Have Clinical Depression?
Yes. Depression and intellectual disability are different clinical concepts and may coexist. Clinicians diagnose depression through an appropriate assessment of symptoms, duration, functional change, context, differential diagnoses, and safety. Adapted communication and observations across time make assessment more accessible. NICE NG54.
Is Aggression or Self-Injury a Sign of Depression?
It can accompany psychological distress, including depression, but it is not specific to depression. Pain, trauma, communication barriers, sensory stress, medical illness, environmental demands, and other mental-health conditions must be assessed. Urgent safety or medical concerns take priority. NICE NG11; NICE NG54.
Can Depression Be Diagnosed When Someone Uses Few or No Spoken Words?
A clinical evaluation can still be undertaken through communication supports, careful knowledge of the person's baseline, direct observation, longitudinal evidence, and contextual accounts. The degree of diagnostic certainty may depend on how reliably particular symptoms can be established. Proxy observations contribute evidence without replacing efforts to understand the person's own communication. NICE NG54.
Does the Glasgow Depression Scale Diagnose Depression?
No. The Glasgow Depression Scale and its carer supplement are structured aids for recognizing and monitoring symptoms. They must be interpreted within a complete assessment and in light of the individual's communication, functioning, medical history, and the instrument's validation population. Cuthill, Espie, and Cooper (2003).
Does Cognitive Behavioral Therapy Work for Intellectual Disability?
Adapted CBT is recommended for consideration in adults with milder intellectual disability who have depression or subthreshold symptoms. Specialist studies suggest potential benefit, but the evidence base is smaller and less conclusive than the general adult depression literature. Suitability and adaptations should be individualized. NICE NG54; Hamers et al. (2018).
Are Antidepressants Appropriate?
They may be, when depressive illness has been evaluated and the expected benefits, risks, alternatives, and the person's preferences have been considered. Specialist input is particularly important for people with more severe intellectual disability, children, adolescents, polypharmacy, or complex neurological conditions. The treatment plan needs accessible monitoring for response and adverse effects. NICE NG54; NICE NG222.
When Should Someone Seek Immediate Help?
Seek urgent clinical or emergency help for suicidal intent, potentially life-threatening self-injury, inability to maintain basic safety, rapidly worsening confusion or distress, or other acute danger. A clinician should assess risk directly using appropriate communication supports and medical evaluation. Existing intellectual disability does not make a warning sign less important. NICE NG54.
Related Articles
Diagnostic Overshadowing in Intellectual Disability: How Conditions Are Missed — why co-occurring medical and psychiatric problems can be overlooked when symptoms are attributed to a developmental diagnosis.
Mental Health Problems in People With Intellectual Disability: Recognition and Care — the broader mental-health assessment and care framework in intellectual disability.
Challenging Behavior in Intellectual Disability: Causes, Assessment, and Support — interpretation of behavior within medical, psychological, communicative, and environmental contexts.
Autism and Intellectual Disability in Adults: Differences and Support — the separate differential and support questions when autism and intellectual disability coexist.
What Is Intellectual Disability? Definition, Characteristics, and Support — the developmental diagnostic framework and understanding of intellectual and adaptive functioning.
Anxiety in People With Intellectual Disability: Assessment and Support — Anxiety identification and effective clinical support in ID.
References
American Association on Intellectual and Developmental Disabilities. (n.d.). Defining criteria for intellectual disability. AAIDD official definition.
Cuthill, F. M., Espie, C. A., and Cooper, S.-A. (2003). Development and psychometric properties of the Glasgow Depression Scale for people with a Learning Disability: Individual and carer supplement versions. British Journal of Psychiatry, 182(4), 347–353. https://doi.org/10.1192/bjp.182.4.347.
Deb, S., Perera, B., Krysta, K., Ozer, M., Bertelli, M., Novell, R., Wieland, J., and Sappok, T. (2022). The European guideline on the assessment and diagnosis of psychiatric disorders in adults with intellectual disabilities. European Journal of Psychiatry, 36(1), 11–25. https://doi.org/10.1016/j.ejpsy.2021.10.002.
Gillooly, A., Dagnan, D., Hastings, R., Hatton, C., McMeekin, N., Baines, S., Cooper, S.-A., Crawford, L., Gillespie, D., Miller, J., and Jahoda, A. (2024). Behavioural activation for depressive symptoms in adults with severe to profound intellectual disabilities: Modelling and initial feasibility study. Journal of Applied Research in Intellectual Disabilities, 37(2), e13197. https://doi.org/10.1111/jar.13197.
Hamers, P. C. M., Festen, D. A. M., and Hermans, H. (2018). Non-pharmacological interventions for adults with intellectual disabilities and depression: A systematic review. Journal of Intellectual Disability Research, 62(8), 684–700. https://doi.org/10.1111/jir.12502.
Hartley, S. L., Esbensen, A. J., Shalev, R., Vincent, L. B., Mihaila, I., and Bussanich, P. (2015). Cognitive behavioral therapy for depressed adults with mild intellectual disability: A pilot study. Journal of Mental Health Research in Intellectual Disabilities, 8(2), 72–97. https://doi.org/10.1080/19315864.2015.1033573.
Jahoda, A., Hastings, R., Hatton, C., and colleagues. (2017). Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: A randomised controlled trial. The Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(17)30426-130426-1).
National Institute for Health and Care Excellence. (2015). Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges (NG11). https://www.nice.org.uk/guidance/ng11.
National Institute for Health and Care Excellence. (2016; reviewed 2024). Mental health problems in people with learning disabilities: Prevention, assessment and management (NG54). https://www.nice.org.uk/guidance/ng54.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). https://www.nice.org.uk/guidance/ng222.
National Institute for Health and Care Research. (2018). Behavioural activation versus guided self-help for depression in adults with learning disabilities: The BeatIt randomized controlled trial. Health Technology Assessment, 22(53). https://doi.org/10.3310/hta22530.